DADC
LSTA icon

D.A. Davidson & Co’s Lisata Therapeutics LSTA Stock Holding History

D.A. Davidson & Co’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3
Closed – – 2309
2015
Q4 		$0 Hold
3
– – ﹤0.01% 2252
2015
Q3 		$0 Buy
+3
New +$753 ﹤0.01% 2241
2014
Q3 		– Sell
-3
Closed -$2K – 2143
2014
Q2 		$2K Buy
+3
New +$2.92K ﹤0.01% 2037

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

D.A. Davidson & Co's LSTA Position: Q1 2016 in Review

D.A. Davidson & Co sold out of Lisata Therapeutics (LSTA) in Q1 2016, closing a stake of 3 shares.

D.A. Davidson & Co first reported a position in LSTA in Q2 2014 and held it in 3 quarters. The position peaked at $2K in Q2 2014. 44 funds tracked by Wall St. Rank hold LSTA as of Q1 2016.

  • D.A. Davidson & Co reported no remaining Lisata Therapeutics position as of Q1 2016 after selling out during the quarter.
  • D.A. Davidson & Co sold 3 Lisata Therapeutics shares in Q1 2016.
  • D.A. Davidson & Co first reported a position in Lisata Therapeutics in Q2 2014 and held it in 3 quarters.
  • D.A. Davidson & Co's Lisata Therapeutics position peaked at $2K in Q2 2014.
  • 44 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2016.

Based on D.A. Davidson & Co's 13F filing for Q1 2016, filed 13 May 2016.